Akero Therapeutics Inc buy Morgan Stanley
Start price
10.03.25
/
50%
€38.28
Target price
10.03.26
-
Performance (%)
22.70%
End price
11.03.26
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 22.70%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by Morgan_Stanley for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€49.44
28.01.25
28.01.25
€92.02
28.01.26
28.01.26
-5.00%
29.01.26
29.01.26
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€14.00
11.10.23
11.10.23
€31.05
11.10.24
11.10.24
92.86%
12.10.24
12.10.24